Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.
|
|
For the Three Months
Ended June 30,
|
|
|
For the Six Months
Ended June 30,
|
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
Financing Warrant to purchase common stock
|
|
-
|
|
|
|
13,889
|
|
|
-
|
|
|
|
13,889
|
|
IPO Warrants to purchase common stock
|
|
|
-
|
|
|
|
11,600
|
|
|
|
-
|
|
|
|
11,600
|
|
Investor Relations Consulting Warrant
|
|
|
-
|
|
|
|
7,950
|
|
|
|
-
|
|
|
|
7,950
|
|
Investor Relations Incentive Warrant
|
|
|
-
|
|
|
|
15,000
|
|
|
|
-
|
|
|
|
15,000
|
|
Warrant issued to private investors
|
|
|
3,035,688
|
|
|
|
2,381,675
|
|
|
|
3,035,688
|
|
|
|
2,381,675
|
|
Options to purchase common stock
|
|
|
856,635
|
|
|
|
1,153,966
|
|
|
|
856,635
|
|
|
|
1,153,966
|
|
RSUs
|
|
|
2,640,034
|
|
|
|
2,795,103
|
|
|
|
2,640,034
|
|
|
|
2,795,103
|
|
PSUs
|
|
|
871,559
|
|
|
|
1,153,617
|
|
|
|
871,559
|
|
|
|
1,153,617
|
|
Total potentially dilutive securities
|
|
|
7,403,916
|
|
|
|
7,532,800
|
|
|
|
7,403,916
|
|
|
|
7,532,800
|
|
|